IP Verse

Knig Szynka Tilmann Von Renesse competitive analysis

Latest oppositions filed by Knig Szynka Tilmann Von Renesse

Explore patent oppositions filed by Knig Szynka Tilmann Von Renesse against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
EP4108782
Compositions And Methods For Analyte DetectionPRESIDENT AND FELLOWS OF HARVARD COLLEGEMar 7, 2024
EP3265122
Combination Of A Pd-1 Antagonist And Eribulin For Treating CancerEISAI R&D MANAGEMENTJan 23, 2023
EP3827845
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their UsesJANSSEN BIOTECHDec 27, 2022
EP3763820
Retroviral Transduction Using PoloxamersHELMHOLTZ ZENTRUM MNCHEN DEUTSCHES FORSCHUNGSZENTRUM FR GESUNDHEIT UND UMWELTSep 22, 2022
EP3521422
Substantially Animal Protein-Free Recombinat Furin And Methods For Producing SameBAXALTAJul 6, 2022
EP3498734
Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHMEJun 1, 2022
EP3047013
Methods And Systems For Processing A Cell CultureGENZYMEMay 18, 2022
EP3440329
Fuel Exchange System And Fuel Supply System For Fuel SystemsBEFINALNov 17, 2021
EP3218406
Binding Molecules Specific For Cd73 And Uses ThereofMEDIMMUNENov 12, 2021
EP3616720
Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITYOct 14, 2021

Latest PTAB cases involving Knig Szynka Tilmann Von Renesse

Discover the latest PTAB cases involving Knig Szynka Tilmann Von Renesse, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Knig Szynka Tilmann Von Renesse with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
KNIG SZYNKA TILMANN VON RENESSE34 - - -
AMGEN8150811
F HOFFMANN LA ROCHE16197 - -
MERCK SHARP & DOHME2253615